[1]
R. . Sunkara and J. . Chimakurthy, “A Systems Pharmacology Study on Lanifibranor for the Management of Non-Alcoholic Fatty Liver Disease”, CTBP, vol. 20, no. 2A, pp. 174–189, May 2026.